Vita means life. It's also our platform for sharing the stories of biotech's promise to patients and public health.
CSL consists of CSL Behring, CSL Plasma, CSL Seqirus and CSL Vifor. Learn more by visiting each section.
Biotechnology leader CSL Behring offers the broadest range of quality plasma-derived and recombinant therapies in our industry.
Derived from the expression 'securing health for all of us', CSL Seqirus is one of the world's largest influenza vaccine providers.
R&D focuses its expertise on four strategic platforms: plasma protein technology; recombinant technology; cell and gene therapy; and vaccines technology.
One of our core values at CSL is Innovation. We support collaborative innovation through the endowment of awards and grants to researchers around the world.
As part of our broader sustainability strategy to build a more sustainable future, we've committed to a 40% reduction in absolute Scope 1 and 2 emissions by 2030.
Along with our sustainability strategy, CSL’s community contribution framework helps deliver on our Values and support execution of our 2030 strategy.
At CSL, Diversity, Equity, and Inclusion (DEI) is at the core of our mission and who we are. It fuels our innovation day in and day out.
Whether you are early in your college education or recently completed your degree, it's never too soon to consider CSL for your Promising Future!
Watch a video that introduces CSL Vifor’s role as the “home of iron” at its manufacturing site in St. Gallen, Switzerland.
Expanding deep collaboration across industries will help make meaningful advancement on our shared goals.
Just in time for Nobel Prize week, a historian in Marburg, Germany, has authored a biography of von Behring. It reveals the h…
CSL employees put on their walking shoes this month and set out to log 7 million steps – one for each of the 7 million people…
Over the last four years, CSL made a multi-billion investment in Australia, including the new 18-story building in Melbourne’…
On October 15, the National Organization for Rare Disorders (NORD) will welcome patients and thought leaders to Washington, D…
Imagine a comprehensive collection of human antibodies, more than a 100 billion of them, each with the potential to be the ne…
CSL Seqirus Project Manager Mike Buckland awarded Member of the Order of the British Empire for his volunteer service with t…
Once dismissed, inquiring patients are now encouraged to come with prepared questions, which may decrease worry and lead to a…
Americas
Asia Pacific
Middle East
Europe
